|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:STARD10-CPT1A (FusionGDB2 ID:86549) |
Fusion Gene Summary for STARD10-CPT1A |
Fusion gene summary |
Fusion gene information | Fusion gene name: STARD10-CPT1A | Fusion gene ID: 86549 | Hgene | Tgene | Gene symbol | STARD10 | CPT1A | Gene ID | 10809 | 1374 |
Gene name | StAR related lipid transfer domain containing 10 | carnitine palmitoyltransferase 1A | |
Synonyms | CGI-52|NY-CO-28|PCTP2|SDCCAG28 | CPT1|CPT1-L|L-CPT1 | |
Cytomap | 11q13.4 | 11q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | START domain-containing protein 10PCTP-LPCTP-like proteinSTART domain containing 10StAR-related lipid transfer (START) domain containing 10antigen NY-CO-28serologically defined colon cancer antigen 28stAR-related lipid transfer protein 10 | carnitine O-palmitoyltransferase 1, liver isoformCPT ICPTI-Lcarnitine O-palmitoyltransferase I, liver isoformcarnitine palmitoyltransferase 1A (liver)carnitine palmitoyltransferase I, liver | |
Modification date | 20200313 | 20200315 | |
UniProtAcc | . | P50416 | |
Ensembl transtripts involved in fusion gene | ENST00000543304, ENST00000334805, ENST00000538536, ENST00000538437, ENST00000545082, | ENST00000540367, ENST00000376618, ENST00000265641, ENST00000539743, ENST00000537756, ENST00000538994, | |
Fusion gene scores | * DoF score | 10 X 7 X 6=420 | 12 X 9 X 8=864 |
# samples | 10 | 15 | |
** MAII score | log2(10/420*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/864*10)=-2.52606881166759 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: STARD10 [Title/Abstract] AND CPT1A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | STARD10(72492019)-CPT1A(68562379), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | STARD10-CPT1A seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. STARD10-CPT1A seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CPT1A | GO:0001676 | long-chain fatty acid metabolic process | 11350182 |
Tgene | CPT1A | GO:0009437 | carnitine metabolic process | 11350182 |
Fusion gene breakpoints across STARD10 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CPT1A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8362 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
Top |
Fusion Gene ORF analysis for STARD10-CPT1A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000543304 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
Frame-shift | ENST00000543304 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
Frame-shift | ENST00000543304 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
Frame-shift | ENST00000543304 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5CDS-intron | ENST00000543304 | ENST00000537756 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5CDS-intron | ENST00000543304 | ENST00000538994 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
In-frame | ENST00000334805 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
In-frame | ENST00000334805 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
In-frame | ENST00000334805 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
In-frame | ENST00000334805 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5CDS-intron | ENST00000334805 | ENST00000537756 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5CDS-intron | ENST00000334805 | ENST00000538994 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000538536 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000538536 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000538536 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000538536 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-intron | ENST00000538536 | ENST00000537756 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-intron | ENST00000538536 | ENST00000538994 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-3CDS | ENST00000538437 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-3CDS | ENST00000538437 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-3CDS | ENST00000538437 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-3CDS | ENST00000538437 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-intron | ENST00000538437 | ENST00000537756 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
5UTR-intron | ENST00000538437 | ENST00000538994 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000545082 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000545082 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000545082 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-3CDS | ENST00000545082 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-intron | ENST00000545082 | ENST00000537756 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
intron-intron | ENST00000545082 | ENST00000538994 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000334805 | STARD10 | chr11 | 72492019 | - | ENST00000540367 | CPT1A | chr11 | 68562379 | - | 2823 | 1127 | 776 | 2626 | 616 |
ENST00000334805 | STARD10 | chr11 | 72492019 | - | ENST00000376618 | CPT1A | chr11 | 68562379 | - | 2821 | 1127 | 776 | 2626 | 616 |
ENST00000334805 | STARD10 | chr11 | 72492019 | - | ENST00000265641 | CPT1A | chr11 | 68562379 | - | 5433 | 1127 | 776 | 2677 | 633 |
ENST00000334805 | STARD10 | chr11 | 72492019 | - | ENST00000539743 | CPT1A | chr11 | 68562379 | - | 2709 | 1127 | 776 | 2677 | 633 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000334805 | ENST00000540367 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - | 0.004028572 | 0.9959714 |
ENST00000334805 | ENST00000376618 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - | 0.004096705 | 0.9959033 |
ENST00000334805 | ENST00000265641 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - | 0.002047941 | 0.99795204 |
ENST00000334805 | ENST00000539743 | STARD10 | chr11 | 72492019 | - | CPT1A | chr11 | 68562379 | - | 0.004178687 | 0.99582136 |
Top |
Fusion Genomic Features for STARD10-CPT1A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for STARD10-CPT1A |
Go to FGviewer for the breakpoints of chr11:72492019-chr11:68562379 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | CPT1A |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:9691089, PubMed:11350182, PubMed:14517221). Plays an important role in hepatic triglyceride metabolism (By similarity). {ECO:0000250|UniProtKB:P32198, ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:9691089}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 555_567 | 257.0 | 774.0 | Region | Coenzyme A binding | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 555_567 | 257.0 | 757.0 | Region | Coenzyme A binding | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 555_567 | 257.0 | 774.0 | Region | Coenzyme A binding | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 555_567 | 257.0 | 757.0 | Region | Coenzyme A binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | STARD10 | chr11:72492019 | chr11:68562379 | ENST00000334805 | - | 2 | 7 | 14_224 | 69.0 | 292.0 | Domain | START |
Hgene | STARD10 | chr11:72492019 | chr11:68562379 | ENST00000543304 | - | 3 | 8 | 14_224 | 69.0 | 292.0 | Domain | START |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 123_773 | 257.0 | 774.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 2_47 | 257.0 | 774.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 74_102 | 257.0 | 774.0 | Topological domain | Mitochondrial intermembrane | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 123_773 | 257.0 | 757.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 2_47 | 257.0 | 757.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 74_102 | 257.0 | 757.0 | Topological domain | Mitochondrial intermembrane | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 123_773 | 257.0 | 774.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 2_47 | 257.0 | 774.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 74_102 | 257.0 | 774.0 | Topological domain | Mitochondrial intermembrane | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 123_773 | 257.0 | 757.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 2_47 | 257.0 | 757.0 | Topological domain | Cytoplasmic | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 74_102 | 257.0 | 757.0 | Topological domain | Mitochondrial intermembrane | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 103_122 | 257.0 | 774.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000265641 | 6 | 19 | 48_73 | 257.0 | 774.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 103_122 | 257.0 | 757.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000376618 | 6 | 19 | 48_73 | 257.0 | 757.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 103_122 | 257.0 | 774.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000539743 | 5 | 18 | 48_73 | 257.0 | 774.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 103_122 | 257.0 | 757.0 | Transmembrane | Helical | |
Tgene | CPT1A | chr11:72492019 | chr11:68562379 | ENST00000540367 | 5 | 18 | 48_73 | 257.0 | 757.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for STARD10-CPT1A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000334805_ENST00000540367_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(transcript)=2823nt_BP=1127nt ACGTGGGGGCGCCTGAGCGAAGATAACCGTAATAAATAGTAACCTAACGGTCCAGTCATCGTTCTGTGGTCCTTTCTTTTATGATTCACA AGGAATGACCCTCTTCATCGCCTCTCCTAATTCAGTCCTCACAACAGTCCTTTTACAAATGGGACAACAGGTTAGAGGAAGTCAGGCAGA TTTCCAGCATCATAGAGAGTAAAGGACCAGGGAAGGATCAGGATTCAAGGACTGCACCCAGGCTCTGCTTCCAGCTTGCTGTGTGACTTT GGGTAATTTTGTTCCCTTAGGGAACTGAGCTTTCTCATTTGTAAATGCAAACAGGCTGTTGGGAGGATCAAATGAGATCCAGGGGTGAAA ACAGCTTAGTTTACTTTCAGGAATTTACCCACGCGGTATATAAAGGCAAAATATTATTATAGTCAGGTGATTGTAGATTGAGGAACCCAT TTCCTCATTCTGCAAATTGCAAACCTGAGGGCCCAAAGAGGGACAGGGGCTTGCCCCAGGTCTCAGCAGGCTGTGAGCAAGAGCTAAAGC CTAATCCTCCTGCCTTTGGGCCTGGAGCCCTTCCTTGTACCCCAGGGGTCAGTGTCTTTGTTGGATACAGGCTTAGATTGACTGACTGTA CCCTGAGAACCTAGGGGAGTCCCTGTTCCCAATTCTTCTCCTACCCCCACCTTGGCCTGATGGAGGAAGACCCTGCTGTGTTGAGATGAG CACCAGAGCCAAGAAGCTGAGGAGGATCTGGAGAATTCTGGAGGAAGAGGAGAGTGTTGCTGGAGCTGTACAGACCCTGCTTCTCAGGTC CCAGGAAGGTGGCGTCAGCATCTGCAGCCGCGTCGACGTTGTCGGAGCCTCCGCGGAGGACCCAGGAGAGCCGGACTAGGACCAGGGCCC TGGGCCTCCCCACACTCCCCATGGAGAAGCTGGCGGCCTCTACAGAGCCCCAAGGGCCTCGGCCGGTCCTGGGCCGTGAGAGTGTCCAGG TGCCCGATGACCAAGACTTTCGCAGCTTCCGGTCAGAGTGTGAGGCTGAGGTGGGCTGGAACCTGACCTATAGCAGGGCTGGGGTGTCTG TCTGGGTGCAGGCTGTGGAGATGGATCGGACGCTGCACAAGATCAAGGATCTGCTGTATATCCTTCCAACTCACATTCAGGCAGCAAGAG CCGGCAACGCCATCCATGCCATCCTGCTTTACAGGCGCAAACTGGACCGGGAGGAAATCAAACCAATTCGTCTTTTGGGATCCACGATTC CACTCTGCTCCGCTCAGTGGGAGCGGATGTTTAATACTTCCCGGATCCCAGGAGAGGAGACAGACACCATCCAGCACATGAGAGACAGCA AGCACATCGTCGTGTACCATCGAGGACGCTACTTCAAGGTCTGGCTCTACCATGATGGGCGGCTGCTGAAGCCCCGGGAGATGGAGCAGC AGATGCAGAGGATCCTGGACAATACCTCGGAGCCTCAGCCCGGGGAGGCCAGGCTGGCAGCCCTCACCGCAGGAGACAGAGTTCCCTGGG CCAGGTGTCGTCAGGCCTATTTTGGACGTGGGAAAAATAAGCAGTCTCTTGATGCTGTGGAGAAAGCAGCGTTCTTTGTGACGTTAGATG AAACTGAAGAAGGATACAGAAGTGAAGACCCGGATACGTCAATGGACAGCTACGCCAAATCTCTACTACACGGCCGATGTTACGACAGGT GGTTTGACAAGTCGTTCACGTTTGTTGTCTTCAAAAACGGGAAGATGGGCCTCAACGCTGAACACTCCTGGGCAGATGCGCCGATCGTGG CCCACCTTTGGGAGTACGTCATGTCCATTGACAGCCTCCAGCTGGGCTATGCGGAGGATGGGCACTGCAAAGGCGACATCAATCCGAACA TTCCGTACCCCACCAGGCTGCAGTGGGACATCCCGGGGGAATGTCAAGAGGTTATAGAGACCTCCCTGAACACCGCAAATCTTCTGGCAA ACGACGTGGATTTCCATTCCTTCCCATTCGTAGCCTTTGGTAAAGGAATCATCAAGAAATGTCGCACGAGCCCAGACGCCTTTGTGCAGC TGGCCCTCCAGCTGGCGCACTACAAGGACATGGGCAAGTTTTGCCTCACATACGAGGCCTCCATGACCCGGCTCTTCCGAGAGGGGAGGA CGGAGACCGTGCGCTCCTGCACCACTGAGTCATGCGACTTCGTGCGGGCCATGGTGGACCCGGCCCAGACGGTGGAACAGAGGCTGAAGT TGTTCAAGTTGGCGTCTGAGAAGCATCAGCATATGTATCGCCTCGCCATGACCGGCTCTGGGATCGATCGTCACCTCTTCTGCCTTTACG TGGTGTCTAAATATCTCGCTGTGGAGTCCCCTTTCCTTAAGGAAGTTTTATCTGAGCCTTGGAGATTATCAACAAGCCAGACCCCTCAGC AGCAAGTGGAGCTGTTTGACTTGGAGAATAACCCAGAGTACGTGTCCAGCGGAGGGGGCTTTGGACCGGTTGCTGATGACGGCTATGGTG TGTCGTACATCCTTGTGGGAGAGAACCTCATCAATTTCCACATTTCTTCCAAGTTCTCTTGCCCTGAGACGGGGATTATAAGTCAAGGAC CAAGTTCAGATACTTGAGACAAAGTGGAAAGTCTCAGCATATGGAAACAAGGCCTTGGAGGAGACCATGGACATCACCAAGTTCATGTGC TGGGCTGGAAAGAAAAGCCTGTTGATTTTCACTTGCTGTGCATTTATTCATCCATTCCATTGCCTCAATGCTGAGAACAGTGCCTGACAC >In-frame_ENST00000334805_ENST00000540367_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(amino acids)=616AA_start in transcript=776_stop in transcript=2626 MLELYRPCFSGPRKVASASAAASTLSEPPRRTQESRTRTRALGLPTLPMEKLAASTEPQGPRPVLGRESVQVPDDQDFRSFRSECEAEVG WNLTYSRAGVSVWVQAVEMDRTLHKIKDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGE ETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDA VEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAPIVAHLWEYVMSIDSLQLGYAE DGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDAFVQLALQLAHYKDMGKFCLTYE ASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSE -------------------------------------------------------------- >In-frame_ENST00000334805_ENST00000376618_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(transcript)=2821nt_BP=1127nt ACGTGGGGGCGCCTGAGCGAAGATAACCGTAATAAATAGTAACCTAACGGTCCAGTCATCGTTCTGTGGTCCTTTCTTTTATGATTCACA AGGAATGACCCTCTTCATCGCCTCTCCTAATTCAGTCCTCACAACAGTCCTTTTACAAATGGGACAACAGGTTAGAGGAAGTCAGGCAGA TTTCCAGCATCATAGAGAGTAAAGGACCAGGGAAGGATCAGGATTCAAGGACTGCACCCAGGCTCTGCTTCCAGCTTGCTGTGTGACTTT GGGTAATTTTGTTCCCTTAGGGAACTGAGCTTTCTCATTTGTAAATGCAAACAGGCTGTTGGGAGGATCAAATGAGATCCAGGGGTGAAA ACAGCTTAGTTTACTTTCAGGAATTTACCCACGCGGTATATAAAGGCAAAATATTATTATAGTCAGGTGATTGTAGATTGAGGAACCCAT TTCCTCATTCTGCAAATTGCAAACCTGAGGGCCCAAAGAGGGACAGGGGCTTGCCCCAGGTCTCAGCAGGCTGTGAGCAAGAGCTAAAGC CTAATCCTCCTGCCTTTGGGCCTGGAGCCCTTCCTTGTACCCCAGGGGTCAGTGTCTTTGTTGGATACAGGCTTAGATTGACTGACTGTA CCCTGAGAACCTAGGGGAGTCCCTGTTCCCAATTCTTCTCCTACCCCCACCTTGGCCTGATGGAGGAAGACCCTGCTGTGTTGAGATGAG CACCAGAGCCAAGAAGCTGAGGAGGATCTGGAGAATTCTGGAGGAAGAGGAGAGTGTTGCTGGAGCTGTACAGACCCTGCTTCTCAGGTC CCAGGAAGGTGGCGTCAGCATCTGCAGCCGCGTCGACGTTGTCGGAGCCTCCGCGGAGGACCCAGGAGAGCCGGACTAGGACCAGGGCCC TGGGCCTCCCCACACTCCCCATGGAGAAGCTGGCGGCCTCTACAGAGCCCCAAGGGCCTCGGCCGGTCCTGGGCCGTGAGAGTGTCCAGG TGCCCGATGACCAAGACTTTCGCAGCTTCCGGTCAGAGTGTGAGGCTGAGGTGGGCTGGAACCTGACCTATAGCAGGGCTGGGGTGTCTG TCTGGGTGCAGGCTGTGGAGATGGATCGGACGCTGCACAAGATCAAGGATCTGCTGTATATCCTTCCAACTCACATTCAGGCAGCAAGAG CCGGCAACGCCATCCATGCCATCCTGCTTTACAGGCGCAAACTGGACCGGGAGGAAATCAAACCAATTCGTCTTTTGGGATCCACGATTC CACTCTGCTCCGCTCAGTGGGAGCGGATGTTTAATACTTCCCGGATCCCAGGAGAGGAGACAGACACCATCCAGCACATGAGAGACAGCA AGCACATCGTCGTGTACCATCGAGGACGCTACTTCAAGGTCTGGCTCTACCATGATGGGCGGCTGCTGAAGCCCCGGGAGATGGAGCAGC AGATGCAGAGGATCCTGGACAATACCTCGGAGCCTCAGCCCGGGGAGGCCAGGCTGGCAGCCCTCACCGCAGGAGACAGAGTTCCCTGGG CCAGGTGTCGTCAGGCCTATTTTGGACGTGGGAAAAATAAGCAGTCTCTTGATGCTGTGGAGAAAGCAGCGTTCTTTGTGACGTTAGATG AAACTGAAGAAGGATACAGAAGTGAAGACCCGGATACGTCAATGGACAGCTACGCCAAATCTCTACTACACGGCCGATGTTACGACAGGT GGTTTGACAAGTCGTTCACGTTTGTTGTCTTCAAAAACGGGAAGATGGGCCTCAACGCTGAACACTCCTGGGCAGATGCGCCGATCGTGG CCCACCTTTGGGAGTACGTCATGTCCATTGACAGCCTCCAGCTGGGCTATGCGGAGGATGGGCACTGCAAAGGCGACATCAATCCGAACA TTCCGTACCCCACCAGGCTGCAGTGGGACATCCCGGGGGAATGTCAAGAGGTTATAGAGACCTCCCTGAACACCGCAAATCTTCTGGCAA ACGACGTGGATTTCCATTCCTTCCCATTCGTAGCCTTTGGTAAAGGAATCATCAAGAAATGTCGCACGAGCCCAGACGCCTTTGTGCAGC TGGCCCTCCAGCTGGCGCACTACAAGGACATGGGCAAGTTTTGCCTCACATACGAGGCCTCCATGACCCGGCTCTTCCGAGAGGGGAGGA CGGAGACCGTGCGCTCCTGCACCACTGAGTCATGCGACTTCGTGCGGGCCATGGTGGACCCGGCCCAGACGGTGGAACAGAGGCTGAAGT TGTTCAAGTTGGCGTCTGAGAAGCATCAGCATATGTATCGCCTCGCCATGACCGGCTCTGGGATCGATCGTCACCTCTTCTGCCTTTACG TGGTGTCTAAATATCTCGCTGTGGAGTCCCCTTTCCTTAAGGAAGTTTTATCTGAGCCTTGGAGATTATCAACAAGCCAGACCCCTCAGC AGCAAGTGGAGCTGTTTGACTTGGAGAATAACCCAGAGTACGTGTCCAGCGGAGGGGGCTTTGGACCGGTTGCTGATGACGGCTATGGTG TGTCGTACATCCTTGTGGGAGAGAACCTCATCAATTTCCACATTTCTTCCAAGTTCTCTTGCCCTGAGACGGGGATTATAAGTCAAGGAC CAAGTTCAGATACTTGAGACAAAGTGGAAAGTCTCAGCATATGGAAACAAGGCCTTGGAGGAGACCATGGACATCACCAAGTTCATGTGC TGGGCTGGAAAGAAAAGCCTGTTGATTTTCACTTGCTGTGCATTTATTCATCCATTCCATTGCCTCAATGCTGAGAACAGTGCCTGACAC >In-frame_ENST00000334805_ENST00000376618_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(amino acids)=616AA_start in transcript=776_stop in transcript=2626 MLELYRPCFSGPRKVASASAAASTLSEPPRRTQESRTRTRALGLPTLPMEKLAASTEPQGPRPVLGRESVQVPDDQDFRSFRSECEAEVG WNLTYSRAGVSVWVQAVEMDRTLHKIKDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGE ETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDA VEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAPIVAHLWEYVMSIDSLQLGYAE DGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDAFVQLALQLAHYKDMGKFCLTYE ASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSE -------------------------------------------------------------- >In-frame_ENST00000334805_ENST00000265641_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(transcript)=5433nt_BP=1127nt ACGTGGGGGCGCCTGAGCGAAGATAACCGTAATAAATAGTAACCTAACGGTCCAGTCATCGTTCTGTGGTCCTTTCTTTTATGATTCACA AGGAATGACCCTCTTCATCGCCTCTCCTAATTCAGTCCTCACAACAGTCCTTTTACAAATGGGACAACAGGTTAGAGGAAGTCAGGCAGA TTTCCAGCATCATAGAGAGTAAAGGACCAGGGAAGGATCAGGATTCAAGGACTGCACCCAGGCTCTGCTTCCAGCTTGCTGTGTGACTTT GGGTAATTTTGTTCCCTTAGGGAACTGAGCTTTCTCATTTGTAAATGCAAACAGGCTGTTGGGAGGATCAAATGAGATCCAGGGGTGAAA ACAGCTTAGTTTACTTTCAGGAATTTACCCACGCGGTATATAAAGGCAAAATATTATTATAGTCAGGTGATTGTAGATTGAGGAACCCAT TTCCTCATTCTGCAAATTGCAAACCTGAGGGCCCAAAGAGGGACAGGGGCTTGCCCCAGGTCTCAGCAGGCTGTGAGCAAGAGCTAAAGC CTAATCCTCCTGCCTTTGGGCCTGGAGCCCTTCCTTGTACCCCAGGGGTCAGTGTCTTTGTTGGATACAGGCTTAGATTGACTGACTGTA CCCTGAGAACCTAGGGGAGTCCCTGTTCCCAATTCTTCTCCTACCCCCACCTTGGCCTGATGGAGGAAGACCCTGCTGTGTTGAGATGAG CACCAGAGCCAAGAAGCTGAGGAGGATCTGGAGAATTCTGGAGGAAGAGGAGAGTGTTGCTGGAGCTGTACAGACCCTGCTTCTCAGGTC CCAGGAAGGTGGCGTCAGCATCTGCAGCCGCGTCGACGTTGTCGGAGCCTCCGCGGAGGACCCAGGAGAGCCGGACTAGGACCAGGGCCC TGGGCCTCCCCACACTCCCCATGGAGAAGCTGGCGGCCTCTACAGAGCCCCAAGGGCCTCGGCCGGTCCTGGGCCGTGAGAGTGTCCAGG TGCCCGATGACCAAGACTTTCGCAGCTTCCGGTCAGAGTGTGAGGCTGAGGTGGGCTGGAACCTGACCTATAGCAGGGCTGGGGTGTCTG TCTGGGTGCAGGCTGTGGAGATGGATCGGACGCTGCACAAGATCAAGGATCTGCTGTATATCCTTCCAACTCACATTCAGGCAGCAAGAG CCGGCAACGCCATCCATGCCATCCTGCTTTACAGGCGCAAACTGGACCGGGAGGAAATCAAACCAATTCGTCTTTTGGGATCCACGATTC CACTCTGCTCCGCTCAGTGGGAGCGGATGTTTAATACTTCCCGGATCCCAGGAGAGGAGACAGACACCATCCAGCACATGAGAGACAGCA AGCACATCGTCGTGTACCATCGAGGACGCTACTTCAAGGTCTGGCTCTACCATGATGGGCGGCTGCTGAAGCCCCGGGAGATGGAGCAGC AGATGCAGAGGATCCTGGACAATACCTCGGAGCCTCAGCCCGGGGAGGCCAGGCTGGCAGCCCTCACCGCAGGAGACAGAGTTCCCTGGG CCAGGTGTCGTCAGGCCTATTTTGGACGTGGGAAAAATAAGCAGTCTCTTGATGCTGTGGAGAAAGCAGCGTTCTTTGTGACGTTAGATG AAACTGAAGAAGGATACAGAAGTGAAGACCCGGATACGTCAATGGACAGCTACGCCAAATCTCTACTACACGGCCGATGTTACGACAGGT GGTTTGACAAGTCGTTCACGTTTGTTGTCTTCAAAAACGGGAAGATGGGCCTCAACGCTGAACACTCCTGGGCAGATGCGCCGATCGTGG CCCACCTTTGGGAGTACGTCATGTCCATTGACAGCCTCCAGCTGGGCTATGCGGAGGATGGGCACTGCAAAGGCGACATCAATCCGAACA TTCCGTACCCCACCAGGCTGCAGTGGGACATCCCGGGGGAATGTCAAGAGGTTATAGAGACCTCCCTGAACACCGCAAATCTTCTGGCAA ACGACGTGGATTTCCATTCCTTCCCATTCGTAGCCTTTGGTAAAGGAATCATCAAGAAATGTCGCACGAGCCCAGACGCCTTTGTGCAGC TGGCCCTCCAGCTGGCGCACTACAAGGACATGGGCAAGTTTTGCCTCACATACGAGGCCTCCATGACCCGGCTCTTCCGAGAGGGGAGGA CGGAGACCGTGCGCTCCTGCACCACTGAGTCATGCGACTTCGTGCGGGCCATGGTGGACCCGGCCCAGACGGTGGAACAGAGGCTGAAGT TGTTCAAGTTGGCGTCTGAGAAGCATCAGCATATGTATCGCCTCGCCATGACCGGCTCTGGGATCGATCGTCACCTCTTCTGCCTTTACG TGGTGTCTAAATATCTCGCTGTGGAGTCCCCTTTCCTTAAGGAAGTTTTATCTGAGCCTTGGAGATTATCAACAAGCCAGACCCCTCAGC AGCAAGTGGAGCTGTTTGACTTGGAGAATAACCCAGAGTACGTGTCCAGCGGAGGGGGCTTTGGACCGGTTGCTGATGACGGCTATGGTG TGTCGTACATCCTTGTGGGAGAGAACCTCATCAATTTCCACATTTCTTCCAAGTTCTCTTGCCCTGAGACGGATTCTCATCGCTTTGGAA GGCACCTGAAAGAAGCAATGACTGACATCATCACTTTGTTTGGTCTCAGTTCTAATTCCAAAAAGTAATTCCACTGGAGCTGCTGGGAAG GAAAACGAGCTCTTCTGATGCAAACCAAATGAAAAATAGGCATTAATCCTGACCTTAGCTCGGGATGAAACACTGCTCTTAAAAAAACTC AGTTTTCCTTCCAGAAAATGTGGGTGTTTTTTTTTCCTAGAACAGTATCTCTCCCCTGTGAAGCATAACCCCACTACTTCCAGACTTGCC CTCCCTTGGGGGACATCTGATAAAGTCTCCCCTGATGTCTCCGCATCGGCTTGGATTTATTAAGGGATGCAAATCTTGTTGAGTTAATGA AGGAATTAGTAGGGTTGTGGCTTCACACACAGTGGAATGGAAATGGTGTGCTTTCTCAGTGGCAACCGAAGGCCTAGTGCTTAAGGGCAT TTAGCATCATCCAAGCAGGGTAAACTTTTGTTTTGTTAAAAGAAAAATGTGTTATTCAAGTTGGTGTCCCCAGTTGTAGCTAACACATCT GGAATGCACTAACCAAAATGCTGTGCTTTGGAGACCTGCTTTTGTCACCGTGGGTAACCGTTCCCGTCTGGTCCAGTAGCCTGTGTTTGC CTCTCCACATTTGAAGCAAGCAGGATGCAAGGTCTTCAGTTTTACTGACCTTGTATGTCTTCAAGTCTTCACAACCCAGTGCCTTAAAAA TGAAAGGCCCTAAATGTAAGGGAGATGGAGAGAAAGATTTATTTTGTAGAGTCTTTGGGTGGAATTGTGGGTATACTGTTCCCTTCACAA TTGACTGAGTATGGATAACCGTACATAAGCATTTGCTACACCCCACCAGCCCCCTCCCCCTCAGAAACACCAGTTCCTTCCCAAGGGCAG CTGTGCCAGACTCCCCTCCCGGGACTGCCTTCTTGTCATCATAAGCAACAAAAGAAATAACAGGCACATGTCATAAAAGGGGAGCAAGGG CCGTGATGGTCAGATAATTCACTCAAGAATAAAACATGACACGTGCCTCAGGAGGATCTCTTTCCCAAAGTGACAGCAAGGAGGGCAGGG CATCGGCCACCAAGCGGGGACTAGCAAGTGAGGAAGGGGAGGGCAGCCCACCGTGGTGAGGAGAGAGTGGCTCCACGACCCCAAGGGATG GCCTTCTCCTCCCACCCGGTGAGGGGAAAGACTCACCAGAGGGTGATGGAGACAGTATGCCGGCTCACCTTGGTGACCAGCCAAGATGTC TCAAGTGACAGTGCTAGGTGTTCACCCAGCCTGTCCTTCAGATAGGAGTGCCTTCACGAAAGCGTCTCATGGACCACAAAGCAATTATGC ACTGAGTCATCTTCAGTATTTAATGCAAAAATGAAGCATCATGGAATGAAATTCCCACTGTCTGTCATGACAAGCTTAGCTGTCCATTGT TTTAAATTGTGTATTTATTTTTTTGACCACTTGGTTCTAGTTGGGCCTGACTCCTTCAGAGTGCTGCACCCCGATAGTACAACAGCGATG GCTGAACTGTTGGAGTCGATGGAAGGTGCTTGCCGGAGAACACGTGCCTTTTTTTTTTTTTTTTTTTTTGAGATGGAGTTTCACTCTTGT TGCCCAGGCTGGAGTGCAGTGGTGCAATCTCGGCTCACTGCAGCATCTGCCTTGCAGGTTCAAGCGATTCTCCTGTCTCAGCCTCCCAAG TAGCTGGGATTACACGCCCAACACCATGCCCTGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCATCATATTGGTCAGGCTGGTCTC GAACTCCTGACCTCAGGTGATCCACCTGCCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACCATGCGCGGCCCACATGCATG TTTTATGTATGTATACTTCATGATGTAAAAATCCCACCTTTATGGGCCAAAGATTTTTTTTCTCCTGAAAGCAAGAAAAAATGAAAACAA AAGACAAAAAAAAAAAAAAAAGCGTCCAGGCGCGGTGGCTCATGCGTGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGCGGATCACGAG GTCAGGAGATGGAGACCATCCTGGCTAACACGGTGAAACCCCGTCTCTACTAAAAATTCAAAAAATGAGCCGGGCGTGGTGGCGGGCGCC TGTAGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCGAGATCGCTCCACTGCA CTCCAGCCTGGGCGACAGAGCGAGACTCCGTCTAAAAAAAAAAGCAAAAACAAACCAACAACAAAAGCCCCTGACTGTCCGTCAAGCAGG CAGCGGGGATGTAGCTCTCTCTGCCCTGGGCAAGAATAGCACTTCCCGTTAAAAGCCAGCAGCCGGCGTCAGTCCCTATCAGAGCCAGCT AGATCATGCACTGTTGACCACTGAGCAATCTGTGTTACACTAGAGTTCACAGGGCATTTTGAGTGTAGACGTGAGTGCTTAAACATATTT GGGTTTCTCTCTCAGGTTTTAAATGTTTCAAATGTAATTGTTGCTCATCAGTGCAGTTATCAATGCAATTTTATATTCCTTGAGGGGAGA AAGAGGGGTCTTATTGTACATGTCCAAGGGGGGTGATAAGAGTATTATCTGTTTAATTTAATTGGAACAAACCATTGTCTTAACGCAGCC ATGGTTTGAATTTGTTATCTTGGGCTGACCGGTGCATGTAAATACAGTATGCTCTTTGGATGTAAATCTTAGAAATGCAGTGTGAATGTA >In-frame_ENST00000334805_ENST00000265641_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(amino acids)=633AA_start in transcript=776_stop in transcript=2677 MLELYRPCFSGPRKVASASAAASTLSEPPRRTQESRTRTRALGLPTLPMEKLAASTEPQGPRPVLGRESVQVPDDQDFRSFRSECEAEVG WNLTYSRAGVSVWVQAVEMDRTLHKIKDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGE ETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDA VEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAPIVAHLWEYVMSIDSLQLGYAE DGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDAFVQLALQLAHYKDMGKFCLTYE ASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSE PWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSN -------------------------------------------------------------- >In-frame_ENST00000334805_ENST00000539743_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(transcript)=2709nt_BP=1127nt ACGTGGGGGCGCCTGAGCGAAGATAACCGTAATAAATAGTAACCTAACGGTCCAGTCATCGTTCTGTGGTCCTTTCTTTTATGATTCACA AGGAATGACCCTCTTCATCGCCTCTCCTAATTCAGTCCTCACAACAGTCCTTTTACAAATGGGACAACAGGTTAGAGGAAGTCAGGCAGA TTTCCAGCATCATAGAGAGTAAAGGACCAGGGAAGGATCAGGATTCAAGGACTGCACCCAGGCTCTGCTTCCAGCTTGCTGTGTGACTTT GGGTAATTTTGTTCCCTTAGGGAACTGAGCTTTCTCATTTGTAAATGCAAACAGGCTGTTGGGAGGATCAAATGAGATCCAGGGGTGAAA ACAGCTTAGTTTACTTTCAGGAATTTACCCACGCGGTATATAAAGGCAAAATATTATTATAGTCAGGTGATTGTAGATTGAGGAACCCAT TTCCTCATTCTGCAAATTGCAAACCTGAGGGCCCAAAGAGGGACAGGGGCTTGCCCCAGGTCTCAGCAGGCTGTGAGCAAGAGCTAAAGC CTAATCCTCCTGCCTTTGGGCCTGGAGCCCTTCCTTGTACCCCAGGGGTCAGTGTCTTTGTTGGATACAGGCTTAGATTGACTGACTGTA CCCTGAGAACCTAGGGGAGTCCCTGTTCCCAATTCTTCTCCTACCCCCACCTTGGCCTGATGGAGGAAGACCCTGCTGTGTTGAGATGAG CACCAGAGCCAAGAAGCTGAGGAGGATCTGGAGAATTCTGGAGGAAGAGGAGAGTGTTGCTGGAGCTGTACAGACCCTGCTTCTCAGGTC CCAGGAAGGTGGCGTCAGCATCTGCAGCCGCGTCGACGTTGTCGGAGCCTCCGCGGAGGACCCAGGAGAGCCGGACTAGGACCAGGGCCC TGGGCCTCCCCACACTCCCCATGGAGAAGCTGGCGGCCTCTACAGAGCCCCAAGGGCCTCGGCCGGTCCTGGGCCGTGAGAGTGTCCAGG TGCCCGATGACCAAGACTTTCGCAGCTTCCGGTCAGAGTGTGAGGCTGAGGTGGGCTGGAACCTGACCTATAGCAGGGCTGGGGTGTCTG TCTGGGTGCAGGCTGTGGAGATGGATCGGACGCTGCACAAGATCAAGGATCTGCTGTATATCCTTCCAACTCACATTCAGGCAGCAAGAG CCGGCAACGCCATCCATGCCATCCTGCTTTACAGGCGCAAACTGGACCGGGAGGAAATCAAACCAATTCGTCTTTTGGGATCCACGATTC CACTCTGCTCCGCTCAGTGGGAGCGGATGTTTAATACTTCCCGGATCCCAGGAGAGGAGACAGACACCATCCAGCACATGAGAGACAGCA AGCACATCGTCGTGTACCATCGAGGACGCTACTTCAAGGTCTGGCTCTACCATGATGGGCGGCTGCTGAAGCCCCGGGAGATGGAGCAGC AGATGCAGAGGATCCTGGACAATACCTCGGAGCCTCAGCCCGGGGAGGCCAGGCTGGCAGCCCTCACCGCAGGAGACAGAGTTCCCTGGG CCAGGTGTCGTCAGGCCTATTTTGGACGTGGGAAAAATAAGCAGTCTCTTGATGCTGTGGAGAAAGCAGCGTTCTTTGTGACGTTAGATG AAACTGAAGAAGGATACAGAAGTGAAGACCCGGATACGTCAATGGACAGCTACGCCAAATCTCTACTACACGGCCGATGTTACGACAGGT GGTTTGACAAGTCGTTCACGTTTGTTGTCTTCAAAAACGGGAAGATGGGCCTCAACGCTGAACACTCCTGGGCAGATGCGCCGATCGTGG CCCACCTTTGGGAGTACGTCATGTCCATTGACAGCCTCCAGCTGGGCTATGCGGAGGATGGGCACTGCAAAGGCGACATCAATCCGAACA TTCCGTACCCCACCAGGCTGCAGTGGGACATCCCGGGGGAATGTCAAGAGGTTATAGAGACCTCCCTGAACACCGCAAATCTTCTGGCAA ACGACGTGGATTTCCATTCCTTCCCATTCGTAGCCTTTGGTAAAGGAATCATCAAGAAATGTCGCACGAGCCCAGACGCCTTTGTGCAGC TGGCCCTCCAGCTGGCGCACTACAAGGACATGGGCAAGTTTTGCCTCACATACGAGGCCTCCATGACCCGGCTCTTCCGAGAGGGGAGGA CGGAGACCGTGCGCTCCTGCACCACTGAGTCATGCGACTTCGTGCGGGCCATGGTGGACCCGGCCCAGACGGTGGAACAGAGGCTGAAGT TGTTCAAGTTGGCGTCTGAGAAGCATCAGCATATGTATCGCCTCGCCATGACCGGCTCTGGGATCGATCGTCACCTCTTCTGCCTTTACG TGGTGTCTAAATATCTCGCTGTGGAGTCCCCTTTCCTTAAGGAAGTTTTATCTGAGCCTTGGAGATTATCAACAAGCCAGACCCCTCAGC AGCAAGTGGAGCTGTTTGACTTGGAGAATAACCCAGAGTACGTGTCCAGCGGAGGGGGCTTTGGACCGGTTGCTGATGACGGCTATGGTG TGTCGTACATCCTTGTGGGAGAGAACCTCATCAATTTCCACATTTCTTCCAAGTTCTCTTGCCCTGAGACGGATTCTCATCGCTTTGGAA GGCACCTGAAAGAAGCAATGACTGACATCATCACTTTGTTTGGTCTCAGTTCTAATTCCAAAAAGTAATTCCACTGGAGCTGCTGGGAAG >In-frame_ENST00000334805_ENST00000539743_TCGA-BR-8362_STARD10_chr11_72492019_-_CPT1A_chr11_68562379_length(amino acids)=633AA_start in transcript=776_stop in transcript=2677 MLELYRPCFSGPRKVASASAAASTLSEPPRRTQESRTRTRALGLPTLPMEKLAASTEPQGPRPVLGRESVQVPDDQDFRSFRSECEAEVG WNLTYSRAGVSVWVQAVEMDRTLHKIKDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGE ETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDA VEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAPIVAHLWEYVMSIDSLQLGYAE DGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDAFVQLALQLAHYKDMGKFCLTYE ASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSE PWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSN -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for STARD10-CPT1A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for STARD10-CPT1A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | CPT1A | P50416 | DB01016 | Glyburide | Inhibitor | Small molecule | Approved |
Tgene | CPT1A | P50416 | DB01016 | Glyburide | Inhibitor | Small molecule | Approved |
Tgene | CPT1A | P50416 | DB00583 | Levocarnitine | Activator | Small molecule | Approved|Investigational |
Tgene | CPT1A | P50416 | DB00583 | Levocarnitine | Activator | Small molecule | Approved|Investigational |
Tgene | CPT1A | P50416 | DB01074 | Perhexiline | Inhibitor | Small molecule | Approved|Investigational |
Tgene | CPT1A | P50416 | DB01074 | Perhexiline | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for STARD10-CPT1A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | STARD10 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | STARD10 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | CPT1A | C1829703 | Carnitine palmitoyl transferase 1A deficiency | 13 | CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | CPT1A | C0002152 | Alloxan Diabetes | 1 | CTD_human |
Tgene | CPT1A | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | CPT1A | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Tgene | CPT1A | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | CPT1A | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Tgene | CPT1A | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
Tgene | CPT1A | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
Tgene | CPT1A | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Tgene | CPT1A | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | CPT1A | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | CPT1A | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | CPT1A | C3241937 | Nonalcoholic Steatohepatitis | 1 | CTD_human |
Tgene | CPT1A | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |